Royal Bank of Canada’s BioLife Solutions BLFS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $16.9M | Buy |
885,298
+66,010
| +8% | +$1.46M | ﹤0.01% | 1564 |
|
|
2025
Q4 | $19.8M | Sell |
819,288
-99,948
| -11% | -$2.62M | ﹤0.01% | 1506 |
|
|
2025
Q3 | $23.4M | Buy |
919,236
+127,915
| +16% | +$3.03M | ﹤0.01% | 1521 |
|
|
2025
Q2 | $17M | Buy |
791,321
+93,070
| +13% | +$2.1M | ﹤0.01% | 1654 |
|
|
2025
Q1 | $15.9M | Buy |
698,251
+617,320
| +763% | +$16.3M | ﹤0.01% | 1453 |
|
|
2024
Q4 | $2.1M | Buy |
80,931
+717
| +0.9% | +$17.8K | ﹤0.01% | 2993 |
|
|
2024
Q3 | $2.01M | Sell |
80,214
-607
| -0.8% | -$14.3K | ﹤0.01% | 3001 |
|
|
2024
Q2 | $1.73M | Buy |
80,821
+21,098
| +35% | +$409K | ﹤0.01% | 3012 |
|
|
2024
Q1 | $1.11M | Sell |
59,723
-5,888
| -9% | -$103K | ﹤0.01% | 3381 |
|
|
2023
Q4 | $1.07M | Sell |
65,611
-722
| -1% | -$9.21K | ﹤0.01% | 3620 |
|
|
2023
Q3 | $916K | Sell |
66,333
-1,086
| -2% | -$17.1K | ﹤0.01% | 3509 |
|
|
2023
Q2 | $1.49M | Buy |
67,419
+7,202
| +12% | +$152K | ﹤0.01% | 3065 |
|
|
2023
Q1 | $1.31M | Buy |
60,217
+4,839
| +9% | +$109K | ﹤0.01% | 3142 |
|
|
2022
Q4 | $1.01M | Buy |
55,378
+4,842
| +10% | +$100K | ﹤0.01% | 3492 |
|
|
2022
Q3 | $1.15M | Buy |
50,536
+17,238
| +52% | +$369K | ﹤0.01% | 3331 |
|
|
2022
Q2 | $460K | Sell |
33,298
-1,004
| -3% | -$14.7K | ﹤0.01% | 4165 |
|
|
2022
Q1 | $779K | Buy |
34,302
+8,986
| +35% | +$237K | ﹤0.01% | 3876 |
|
|
2021
Q4 | $943K | Buy |
25,316
+23,272
| +1,139% | +$999K | ﹤0.01% | 3879 |
|
|
2021
Q3 | $87K | Buy |
2,044
+372
| +22% | +$17.9K | ﹤0.01% | 5807 |
|
|
2021
Q2 | $74K | Buy |
1,672
+890
| +114% | +$31.4K | ﹤0.01% | 5774 |
|
|
2021
Q1 | $28K | Sell |
782
-306
| -28% | -$12.1K | ﹤0.01% | 6225 |
|
|
2020
Q4 | $44K | Buy |
1,088
+348
| +47% | +$11.9K | ﹤0.01% | 5710 |
|
|
2020
Q3 | $22K | Buy |
740
+208
| +39% | +$4.49K | ﹤0.01% | 5655 |
|
|
2020
Q2 | $9K | Buy |
532
+3
| +0.6% | +$41 | ﹤0.01% | 5859 |
|
|
2020
Q1 | $5K | Sell |
529
-588
| -53% | -$8.07K | ﹤0.01% | 6025 |
|
|
2019
Q4 | $18K | Buy |
1,117
+617
| +123% | +$10K | ﹤0.01% | 5894 |
|
|
2019
Q3 | $8K | Sell |
500
-29
| -5% | -$544 | ﹤0.01% | 5839 |
|
|
2019
Q2 | $8K | Buy |
529
+29
| +6% | +$506 | ﹤0.01% | 6090 |
|
|
2019
Q1 | $9K | Hold |
500
| – | – | ﹤0.01% | 6027 |
|
|
2018
Q4 | $6K | Sell |
500
-4
| -0.8% | -$48 | ﹤0.01% | 6092 |
|
|
2018
Q3 | $9K | Buy |
504
+4
| +0.8% | +$79 | ﹤0.01% | 6015 |
|
|
2018
Q2 | $6K | Sell |
500
-12
| -2% | -$109 | ﹤0.01% | 5971 |
|
|
2018
Q1 | $3K | Buy |
512
+5
| +1% | +$27 | ﹤0.01% | 6038 |
|
|
2017
Q4 | $3K | Buy |
507
+500
| +7,143% | +$2.88K | ﹤0.01% | 6186 |
|
|
2017
Q3 | $0 | Buy |
+7
| New | +$29 | ﹤0.01% | 6711 |
|
|
2016
Q4 | – | Sell |
-72
| Closed | – | – | 6629 |
|
|
2016
Q3 | $0 | Hold |
72
| – | – | ﹤0.01% | 6393 |
|
|
2016
Q2 | $0 | Hold |
72
| – | – | ﹤0.01% | 6358 |
|
|
2016
Q1 | $0 | Hold |
72
| – | – | ﹤0.01% | 6349 |
|
|
2015
Q4 | $0 | Hold |
72
| – | – | ﹤0.01% | 6631 |
|
|
2015
Q3 | $0 | Hold |
72
| – | – | ﹤0.01% | 6633 |
|
|
2015
Q2 | $0 | Hold |
72
| – | – | ﹤0.01% | 6577 |
|
|
2015
Q1 | $0 | Hold |
72
| – | – | ﹤0.01% | 6131 |
|
|
2014
Q4 | $0 | Hold |
72
| – | – | ﹤0.01% | 6164 |
|
|
2014
Q3 | $0 | Hold |
72
| – | – | ﹤0.01% | 5968 |
|
|
2014
Q2 | $0 | Buy |
+72
| New | +$194 | ﹤0.01% | 5926 |
|
Other funds holding BLFS
CC
VCM
FAM
Royal Bank of Canada's BLFS Position: Q1 2026 in Review
Royal Bank of Canada increased its BioLife Solutions (BLFS) stake by 8.1% in Q1 2026, buying an estimated $1.46M and bringing the position to 885,298 shares worth $16.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1564.
Royal Bank of Canada first reported a position in BLFS in Q2 2014 and has held it in 45 quarters since. The position peaked at $23.4M in Q3 2025. 187 funds tracked by Wall St. Rank hold BLFS as of Q1 2026.
- Royal Bank of Canada held 885,298 shares of BioLife Solutions worth $16.9M as of Q1 2026.
- Royal Bank of Canada bought 66,010 BioLife Solutions shares in Q1 2026, an estimated $1.46M.
- BioLife Solutions made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #1564 holding.
- Royal Bank of Canada first reported a position in BioLife Solutions in Q2 2014 and has held it in 45 quarters since.
- Royal Bank of Canada's BioLife Solutions position peaked at $23.4M in Q3 2025.
- 187 funds tracked by Wall St. Rank held BioLife Solutions as of Q1 2026.
Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.